Phase 1/2a Study of ANPD001 in Parkinson Disease
Phase 1/2a Study of ANPD001 in Parkinson Disease
Enrolling by invitation · NCT06344026 · Registry updated 2026-05-14Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1/2a Study of ANPD001 in Parkinson Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Enrolling by invitation | Phase 1 | 2026-05-14 | NCT06344026 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Aspen Neuroscience | 1 |
| California Institute for Regenerative Medicine (CIRM) | 36 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory University | Atlanta | United States | 262 |
| Feinstein Institutes | Manhasset | United States | 1 |
| Scripps Health | La Jolla | United States | 24 |
| University of Arizona - Banner Health | Tucson | United States | 1 |
| University of California, Irvine | Orange | United States | 29 |
| University of California, Los Angeles | Los Angeles | United States | 142 |
| University of California, San Diego | San Diego | United States | 13 |
| University of California, San Francisco | San Francisco | United States | 294 |
| University of Colorado | Aurora | United States | 147 |